The Protein Content of Extracellular Vesicles Derived from Expanded Human Umbilical Cord Blood-Derived CD133+ and Human Bone Marrow-Derived Mesenchymal Stem Cells Partially Explains Why both Sources are Advantageous for Regenerative Medicine

Stem Cell Reviews and Reports

Volumn 13, Issue 2, 2017, Pages 244-257

  Angulski, Addeli B B ^a   Capriglione, Luiz G ^b   Batista, Michel ^a   Marcon, Bruna H ^a   Senegaglia, Alexandra C ^b   Stimamiglio, Marco A ^a   Correa, Alejandro ^a  

^a INSTITUTO CARLOS CHAGAS   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Expanded CD133+ cells; Extracellular vesicles; Human bone marrow derived mesenchymal stem cells; Paracrine activity; Protein content

Indexed keywords

ALPHA7 INTEGRIN; C TYPE LICTIN DOMAIN FAMILY 14 MEMBER A; CALDESMON; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD63 ANTIGEN; CD97 ANTIGEN; CLAUDIN 11; COMPLEMENT COMPONENT C1Q; CYCLIC AMP DEPENDENT PROTEIN KINASE 1; ENDOGLIN; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2; EPIDIDYMIS LUMINAL PROTEIN 189; GAMMA GLUTAMYLTRANSFERASE 5; HISTONE DEACETYTASE 9; INSULIN GROWTH FACTOR LIKE FAMILY MEMBER 2; INTEGRATOR COMPLEX SUBUNIT 7; KARYOPHERIN; LACTATE DEHYDROGENASE; MEMBRANE PROTEIN; MUCIN 19; MYELOID DERIVED GROWTH FACTOR; OPIORPHIN PREPROPEPTIDE; PALLADIN; PEPTIDES AND PROTEINS; SIALIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN; ZINC FINGER PROTEIN 14; PROTEOME;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CLUSTER ANALYSIS; CONTROLLED STUDY; GENE ONTOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; NECROSIS; OLFACTORY RECEPTOR; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEOMICS; REGENERATIVE MEDICINE; TRANSMISSION ELECTRON MICROSCOPY; BLOOD; BONE MARROW CELL; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; EXOSOME; FETUS BLOOD; LIQUID CHROMATOGRAPHY; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES; TANDEM MASS SPECTROMETRY; ULTRASTRUCTURE;

AC133 ANTIGEN; APOPTOSIS; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; EXOSOMES; EXTRACELLULAR VESICLES; FETAL BLOOD; HUMANS; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, TRANSMISSION; NECROSIS; PROTEOME; PROTEOMICS; REGENERATIVE MEDICINE; TANDEM MASS SPECTROMETRY;

EID: 85008219876     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-016-9715-z     Document Type: Article

References (62)

1. Gnecchi, M., Zhang, Z., Ni, A., & Dzau, V. J. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research, 103(11), 1204–1219.
2. Lázaro-Ibáñez, E., Sanz-Garcia, A., Visakorpi, T., Escobedo-Lucea, C., Siljander, P., & Ayuso-Sacido, A. (2014). Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes. Prostate, 74(14), 1379–1390.
3. Urbanelli, L., Magini, A., Buratta, S., Brozzi, A., Sagini, K., Polchi, A., Tancini, B., & Emiliani, C. (2013). Signaling pathways in exosomes biogenesis, secretion and fate. Genes, 4(2), 152–170.
4. Gatti, S., Bruno, S., Deregibus, M. C., Sordi, A., Cantaluppi, V., Tetta, C., & Camussi, G. (2011). Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia–reperfusion-induced acute and chronic kidney injury. Nephrology, Dialysis, Transplantation, 26(5), 1474–1483.
5. Cantaluppi, V., Gatti, S., Medica, D., Figliolini, F., Bruno, S., Deregibus, M. C., Sordi, A., Biancone, L., Tetta, C., & Camussi, G. (2012). Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia–reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney International, 82(4), 412–427.
6. Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y., & Wang, X. (2012). Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells, 30(7), 1556–1564.
7. Xin, H., Li, Y., Liu, Z., Wang, X., Shang, X., & Cui, Y. (2013). MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells, 31(12), 2737–2746.
8. Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S., Choo, A., & Chen, T. S. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research, 4(3), 214–222.
9. Arslan, F., Lai, R. C., Smeets, M. B., Akeroyd, L., Choo, A., & Aguor, E. N. (2013). Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Research, 10(3), 301–312.
10. Bian, S., Zhang, L., Duan, L., Wang, X., Min, Y., & Yu, H. (2014). Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. Journal of Molecular Medicine, 92(4), 387–397.
11. Kim, H. S., Choi, D. Y., Yun, S. J., Choi, S. M., Kang, J. W., Jung, J. W., Hwang, D., Kim, K. P., & Kim, D. W. (2012). Proteomic analysis of microvesicles derived from human mesenchymal stem cells. Journal of Proteome Research, 11(2), 839–849.
12. Anderson, J. D., Johansson, H. J., Graham, C. S., Vesterlund, M., Pham, M. T., Bramlett, C. S., Montgomery, E. N., et al. (2016). Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappaB signaling. Stem Cells, 34(3), 601–613.
13. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302), 964–966.
14. Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999). VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO Journal, 18(14), 3964–3972.
15. Chen, X., Armstrong, M. A., & Li, G. (2006). Mesenchymal stem cells in immunoregulation. Immunology and Cell Biology, 84, 413–421.
16. Rebelatto, C. K., Aguiar, A. M., Moretão, M. P., Senegaglia, A. C., Hansen, P., Barchiki, F., Oliveira, J., et al. (2008). Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Experimental Biology and Medicine, 233(7), 901–913.
17. Senegaglia, A. C., Barboza, L. A., Dallagiovanna, B., Aita, C. A., Hansen, P., Rebelatto, C. L., Aguiar, A. M., et al. (2010). Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function? Experimental Biology and Medicine, 235(1), 119–129.
18. FlowJo software, http://www.flowjo.com/, 2015. Accessed 14 April 2015.
19. Cox, J., & Mann, M. (2008). MaxQuant enables high peptide identification rates, individualized p.P.B.-range mass accuracies and proteome-wide protein quantification. Nature Biotechnology, 26, 1367–1372.
20. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., & Mann, M. (2011). Andromeda: a peptide search engine integrated into the MaxQuant environment. Journal of Proteome Research, 10(4), 1794–1805.
21. Luber, C. A., Cox, J., Lauterbach, H., Fancke, B., Selbach, M., & Tschopp, J. (2010). Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity, 32(2), 279–289.
22. Pathan, M., Keerthikumar, S., Ang, C. S., Gangoda, L., Quek, C. M. J., Williamson, N. J., Mouradov, D., et al. (2015). FunRich: a standalone tool for functional enrichment analysis. Proteomics, 15(15), 2597–2601.
23. G:profiler software, http://biit.cs.ut.ee/gprofiler/, 2016. Accessed 10 May 2016.
24. Revigo software, http://revigo.irb.hr/, 2016. Accessed 03 July 2016.
25. Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M., Geiger, T., Mann, M., et al. (2016). The Perseus computational platform for comprehensive analysis of (prote)omics data. Nature Methods, 13(9), 731–740.
26. Reus, T. L., Robert, A. W., Da Costa, M. B., Aguiar, A. M., & Stimamiglio, M. A. (2016). Secretome from resident cardiac stromal cells stimulates proliferation, cardiomyogenesis and angiogenesis of progenitor cells. International Journal of Cardiology, 15(221), 396–403.
27. Rao, A. V., & Shaha, C. (2000). Role of glutathione S-transferases in oxidative stress-induced male germ cell apoptosis. Free Radical Biology and Medicine, 29(10), 1015–1027.
28. Demasi, A. P., Pereira, G. A., & Netto, L. E. (2006). Yeast oxidative stress response. Influences of cytosolic thioredoxin peroxidase I and of the mitochondrial functional state. FEBS Journal, 273(4), 805–816.
29. Trachootham, D., Lu, W., Ogasawara, M. A., Valle, N. R. D., & Huang, P. (2008). Redox regulation of cell survival. Antioxidants & Redox Signaling, 10(8), 1343–1374.
30. Bierben, E., Sahiner, U. M., Sackesen, C., Erzur, S., & Kalayci, O. (2012). Oxidative stress and antioxidant defense. World Allergy Organization Journal, 5(1), 9–19.
31. Eldh, M., Ekstrom, K., Valadi, H., Sjostrand, M., Olsson, B., Jernas, M., & Lötvall. (2010). Exosomes communicate protective messages during oxidative stress: possible role of exosomal shuttle RNA. PloS One, 5(12), 1–8, e15353.
32. Lötvall, J., Hill, A. F., Hochberg, F., Buzás, E., Di Vizio, D., Gardiner, C., Gho, Y. S., et al. (2014). Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. Journal of Extracellular Vesicles, 22(3), 26913.
33. Urbich, C., & Dimmeler, S. (2004). Endothelial progenitor cells functional characterization. Trends in Cardiovascular Medicine, 14(8), 318–322.
34. Starke, R. D., Ferraro, F., Paschalaki, K. E., Dryden, N. H., Mckinnon, T. A., Sutton, R. E., Payne, E. M., Haskard, D. O., Hughes, A. D., Cutler, D. F., Laffan, M. A., & Randi, A. M. (2011). Endothelial von Willebrand factor regulates angiogenesis. Blood, 117(3), 1071–1080.
35. Wadhwa, R., Yaguchi, T., Hasan, M. K., Mitsui, Y., Reddel, R. R., & Kaul, S. C. (2002). Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Experimental Cell Research, 274(2), 246–253.
36. He, T., Peterson, T. E., Holmuhamedov, E. L., Terzic, A., Caplice, M. N., Oberley, L. W., & Katusic, Z. S. (2004). Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(11), 2021–2027.
37. Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8(9), 726–762.
38. Van der Does, A. M., Hensbergen, P. J., Bogaards, S. J., Cansoy, M., Deelder, A. M., van Leeuwen, H. C., Drijfhout, J. W., et al. (2012). The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity. Journal of Immunology, 188(10), 5012–5019.
39. Picard-Jean, F., Bouchard, S., Larivée, G., & Bisaillon, M. (2014). The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune lactoferrin protein. Antiviral Research, 111, 13–22.
40. Yadav, G., Prasad, R. L., Jha, B. K., Rai, V., Bhakuni, V., & Datta, K. (2009). Evidence for inhibitory interaction of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) with Streptococcus Pneumoniae hyaluronidase. Journal of Biological Chemistry, 284(6), 3897–3905.
41. Mokarizadeh, A., Delirezh, N., Morshedi, A., Mosayebi, G., Farshid, A. A., & Mardani, K. (2012). Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunology Letters, 147(1–2), 47–54.
42. Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014). Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nature Immunology, 15, 1009–1016.
43. Veevers-Lowe, J., Ball, S. G., Shuttleworth, A., & Kielty, C. M. (2011). Mesenchymal stem cell migration is regulated by fibronectin through alpha 5 beta 1-integrin-mediated activation of PDGFR-beta and potentiation of growth factor signals. Journal of Cell Science, 124, 1288–1300.
44. Hu, K. X., Sun, Q. Y., Guo, M., & Ai, H. S. (2010). The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury. British Journal of Radiology, 83(985), 52–58.
45. Arslan, F., Lai, R. C., Smeets, M. B., Akeroyd, L., Choo, A., Aguor, E. N., Timmersm, L., Van Rjen, H. V., Doevendans, P. A., Pasterkamp, G., Lim, S. K., & De Kleijn, D. P. (2013). Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Research, 10(3), 301–312.
46. De Boer, J., Wang, H. J., & Van Blitterswijk, C. (2004). Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Engineering, 10(3–4), 393–401.
47. Via, A. G., Frizziero, A., & Oliva, F. (2012). Biological properties of mesenchymal stem cells from different sources. Muscles, Ligaments and Tendons Journal, 2(3), 154–162.
48. Vesiclepedia database. http://www.microvesicles.org/, 2016. Accessed 12 June 2016.
49. Docheva, D., Haasters, F., & Schieker, M. (2008). Mesenchymal stem cells and their cell surface receptors. Current Rheumatology Reviews, 4, 155–160.
50. Yoder, M. C. (2012). Human endothelial progenitor cells. Cold Spring Harbor Perspectives in Medicine, 2(7), 1–14, a006692.
51. Thery, C., Boussac, M., Veron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J., & Amigorena, S. (2001). Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. Journal of Immunology, 166(12), 7309–7318.
52. Choi, D. S., Lee, J. M., Park, G. W., Lim, H. W., Bang, J. Y., Kim, Y. K., Kwon, K. H., et al. (2007). Proteomic analysis of microvesicles derived from human colorectal cancer cells. Journal of Proteome Research, 6(12), 4646–4655.
53. Hong, B. S., Cho, J. H., Kim, H., Choi, E. J., Rho, S., Kim, J. H., & Choi, D. S. (2009). Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BioMed Central Genomics, 10(556).
54. Herrera, M. B., Fonsato, V., Gatti, S., Deregibus, M. C., Sordi, A., Cantarella, D., Calogero, R., et al. (2010). Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. Journal of Cellular and Molecular Medicine, 14(6b), 1605–1618.
55. Kolf, C. M., Cho, E., & Tuan, R. S. (2007). Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, selfrenewal and differentiation. Arthritis Research and Therapy, 9(1), 204.
56. Gonzales, P. A., Pisitkun, T., Hoffert, J. D., Tchapyjnikov, D., Star, R. A., Kleta, R., Wang, N. S., et al. (2009). Large-scale proteomics and phosphoproteomics of urinary exosomes. Journal of the American Society of Nephrology, 20(2), 363–379.
57. Looze, C., Yui, D., Leung, L., Ingham, M., Kaler, M., Yao, X., Wu, W. W., et al. (2009). Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein. Biochemical and Biophysical Research Communications, 378(3), 433–438.
58. Mears, R., Craven, R. A., Hanrahan, S., Totty, N., Upton, C., Young, S. L., Patel, P., et al. (2004). Proteomic analysis of melanoma derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics, 4(12), 4019–4031.
59. Ji, H., Erfani, N., Tauro, B. J., Kapp, E. A., Zhu, H. J., Moritz, R. L., Lim, J. W., & Simpson, R. J. (2008). Difference gel electrophoresis analysis of Ras-transformed fibroblast cell-derived exosomes. Electrophoresis, 29(12), 2660–2671.
60. Yoder, M. C., & Ingram, D. A. (2009). Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Current Opinion in Hematology, 16, 269–273.
61. Pasquier, E., & Dias, S. (2010). Endothelial progenitor cells: hope beyond controversy. Current Cancer Drug Targets, 10, 914–921.
62. Balistreri, C. R., Buffa, S., Pisano, C., Lio, D., Ruvolo, G., & Mazzesi, G. (2015). Are endothelial progenitor cells the real solution for cardiovascular diseases? Focus on controversies and perspectives. BioMed Research International, 2015(2015).